SIRT3 Controls Cancer Metabolic Reprogramming by Regulating ROS and HIF
- 8 March 2011
- journal article
- editorial
- Published by Elsevier BV in Cancer Cell
- Vol. 19 (3), 299-300
- https://doi.org/10.1016/j.ccr.2011.03.001
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- SIRT3 Opposes Reprogramming of Cancer Cell Metabolism through HIF1α DestabilizationCancer Cell, 2011
- HIF-1: upstream and downstream of cancer metabolismCurrent Opinion in Genetics & Development, 2010
- A Tumor Suppressor SIRTaintyCancer Cell, 2010
- SIRT3 Is a Mitochondria-Localized Tumor Suppressor Required for Maintenance of Mitochondrial Integrity and Metabolism during StressCancer Cell, 2010
- Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeuticsOncogene, 2009
- Understanding the Warburg Effect: The Metabolic Requirements of Cell ProliferationScience, 2009
- SIRT3 interacts with the daf-16 homolog FOXO3a in the Mitochondria, as well as increases FOXO3a Dependent Gene expressionInternational Journal of Biological Sciences, 2008
- Mitochondrial reactive oxygen species trigger hypoxia-induced transcriptionProceedings of the National Academy of Sciences of the United States of America, 1998
- On Respiratory Impairment in Cancer CellsScience, 1956